Medinet Co., Ltd. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medinet Co., Ltd. with three other
companies in this sector in Japan:
Trans Genic Inc
sales of 2.30 billion Japanese Yen [US$20.29 million]
of which 50%
was CRO Business),
Japan Tissue Engineering Company Limited
(2.14 billion Japanese Yen [US$18.81 million]
of which 96%
was Regenerative Medicine Products Business), and
PhoenixBio Co Ltd
(1.23 billion Japanese Yen [US$10.83 million]
Medinet Co., Ltd. reported sales of ¥1.70 billion (US$15.01 million)
September of 2017.
decrease of 10.8%
versus 2016, when the company's sales were ¥1.91 billion.